Estudo randomizado | Em adultos com Covid-19 e hipoxemia grave, 12 mg vs. 6 mg de dexametasona não resultaram em diferença estatisticamente significativa no número de dias sem terapias de suporte à vida.

Effect of 12 mg vs 6 mg of Dexamethasone on the Number of Days Alive Without Life Support in Adults With COVID-19 and Severe Hypoxemia: The COVID STEROID 2 Randomized Trial – JAMA

Editorial: Glucocorticoid Dose in COVID-19: Lessons for Clinical Trials During a Pandemic – JAMA

Comentário no Twitter

In a randomized trial of patients with #COVID19 and severe hypoxemia, compared with 6 mg of dexamethasone, 12 mg of dexamethasone did not statistically significantly reduce the number of days alive without life support at 28 days https://t.co/BMgLTel4aU pic.twitter.com/WKwI8xCUYO

— JAMA (@JAMA_current) October 21, 2021